Onconase (ONC), which is an amphibian homologue of bovine pancreatic ribonuclease (RNase A), is now undergoing a human clinical trial for the treatment of cancer. ONC is delivered to patients intravenously and is able to kill cancer cells selectively. Hence, ONC has the potential to be the harbinger of a new class of cancer chemotherapeutics based on ribonucleases. Ribonuclease- based chemotherapeutic agents are unrelated to extant chemotherapeutics and thus represent a new stratagem for the clinical treatment of cancer. In contrast to ONC, neither RNase A nor its human homologue-RNase 1-is cytotoxic, despite having 10,000-fold greater catalytic activity than ONC. Moreover, only ONC is immunogenic, and its dosing is limited by renal toxicity. These differential attributes, as well as a desire to understand the biochemical mechanism by which ribonucleases exert specific antitumoral activity, motivate this research proposal.
Specific Aims. The five Specific Aims of this research proposal use ideas and methods from organic chemistry, biochemistry, molecular biology, and cell biology to reveal the mechanism by which ribonucleases exert their specific antitumoral activity, and to enhance that activity. During the next grant period, this intent will be achieved in five Specific Aims.
Aim 1 is to assess the role of cell- surface charge in ribonuclease cytotoxicity.
Aim 2 is to determine the kinetic mechanism of cytosolic entry by ribonucleases.
Aim 3 is to create targeted ribonucleases with highly selective toxicity for cancer cells.
Aim 4 is to reveal the roles of ribonuclease and its cognate inhibitor protein in vivo. Finally, Aim 5 is to use contrast agents and magnetic resonance imagining to report on ribonucleases in vivo. Significance. The results of the research proposed herein will provide a detailed biochemical understanding of the antitumoral activity of ribonucleases, and could ultimately lead to new cancer chemotherapeutics based on variants of an endogenous human enzyme, RNase 1.

Public Health Relevance

This research project is focused on the development of a new class of chemotherapeutic agents for the treatment of cancer. The agents are based on ribonuclease, which is a human enzyme that catalyzes the cleavage of RNA. The goal of the project is to obtain fundamental insights into the relationship between the amino-acid sequence of ribonuclease, its three-dimensional structure, and its biological function, and to use those insights to create novel ribonucleases of potential therapeutic utility.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA073808-16
Application #
8391068
Study Section
Special Emphasis Panel (ZRG1-BCMB-B (02))
Program Officer
Forry, Suzanne L
Project Start
1997-07-10
Project End
2013-11-30
Budget Start
2012-12-01
Budget End
2013-11-30
Support Year
16
Fiscal Year
2013
Total Cost
$291,315
Indirect Cost
$90,955
Name
University of Wisconsin Madison
Department
Biochemistry
Type
Schools of Earth Sciences/Natur
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Tonelli, Marco; Eller, Chelcie H; Singarapu, Kiran K et al. (2015) Assignments of RNase A by ADAPT-NMR and enhancer. Biomol NMR Assign 9:81-8
D'Avino, Chiara; Paciello, Rolando; Riccio, Gennaro et al. (2014) Effects of a second-generation human anti-ErbB2 ImmunoRNase on trastuzumab-resistant tumors and cardiac cells. Protein Eng Des Sel 27:83-8
Lavis, Luke D; Raines, Ronald T (2014) Bright building blocks for chemical biology. ACS Chem Biol 9:855-66
Eller, Chelcie H; Yang, Guangbin; Ouerfelli, Ouathek et al. (2014) Affinity of monoclonal antibodies for Globo-series glycans. Carbohydr Res 397:1-6
Desai, Kevin K; Cheng, Chin L; Bingman, Craig A et al. (2014) A tRNA splicing operon: Archease endows RtcB with dual GTP/ATP cofactor specificity and accelerates RNA ligation. Nucleic Acids Res 42:3931-42
Desai, Kevin K; Bingman, Craig A; Cheng, Chin L et al. (2014) Structure of RNA 3'-phosphate cyclase bound to substrate RNA. RNA 20:1560-6
Eller, Chelcie H; Lomax, Jo E; Raines, Ronald T (2014) Bovine brain ribonuclease is the functional homolog of human ribonuclease 1. J Biol Chem 289:25996-6006
Zasadil, Lauren M; Andersen, Kristen A; Yeum, Dabin et al. (2014) Cytotoxicity of paclitaxel in breast cancer is due to chromosome missegregation on multipolar spindles. Sci Transl Med 6:229ra43
Lomax, Jo E; Bianchetti, Christopher M; Chang, Aram et al. (2014) Functional evolution of ribonuclease inhibitor: insights from birds and reptiles. J Mol Biol 426:3041-56
Sundlass, Nadia K; Eller, Chelcie H; Cui, Qiang et al. (2013) Contribution of electrostatics to the binding of pancreatic-type ribonucleases to membranes. Biochemistry 52:6304-12

Showing the most recent 10 out of 81 publications